MASTER KEY project: A basket/umbrella trial for rare cancers in Japan.

被引：2
|
作者：
Okuma, Hitomi Sumiyoshi
Yonemori, Kan
Shimizu, Toshio
Goto, Yasushi
Honma, Yoshitaka
Morizane, Chigusa
Noguchi, Emi
Sudo, Kazuki
Munakata, Wataru
Sunami, Kuniko
Hiraoka, Nobuyoshi
Kohno, Takashi
Hirakawa, Akihiro
Shibata, Taro
Sukigara, Tamie
Kawai, Akira
Yamamoto, Noboru
Nakamura, Kenichi
Nishida, Toshirou
Fujiwara, Yasuhiro
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.TPS2598
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2598
引用
收藏
页数：1
相关论文
共 26 条
  • [21] Clinical relevance of comprehensive genomic analysis in advanced-stage cancers and rare malignancies: Results from the MASTER trial of the German Cancer Consortium
    Horak, Peter
    Heining, Christoph
    Kreutzfeldt, Simon
    Heilig, Christoph E.
    Moehrmann, Lino
    Gieldon, Laura
    Froehlich, Martina
    Uhrig, Sebastian
    Huebschmann, Daniel
    Beck, Katja
    Richter, Daniela
    Wolf, Stephan
    Pfuetze, Katrin
    Geoerg, Christina
    Meissburger, Bettina
    Klauschen, Frederick
    Ochsenreither, Sebastian
    Folprecht, Gunnar
    Siveke, Jens
    Bauer, Sebastian
    Kindler, Thomas
    Brandts, Christian
    Boerries, Melanie
    von Bubnoff, Nikolas
    Spiekermann, Karsten
    Jost, Philipp J.
    Schulze-Osthoff, Klaus
    Bitzer, Michael
    Schirmacher, Peter
    von Kalle, Christof
    Schlenk, Richard
    Klink, Barbara
    Flutter, Barbara
    Weichert, Wilko
    Stenzinger, Albrecht
    Schroeck, Evelin
    Brors, Benedikt
    Glimm, Hanno
    Froehling, Stefan
    CANCER RESEARCH, 2019, 79 (13)
  • [22] A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers
    Chae, Young Kwang
    Corthell, Lucy
    Patel, Sandip Pravin
    Edwards, Robert
    Scalici, Jennifer M.
    Kim, Hye Sung
    Chung, Liam Il-Young
    Othus, Megan
    Mcleod, Christine M.
    Chen, Helen X.
    Sharon, Elad
    Streicher, Howard
    Ryan, Christopher W.
    Blanke, Charles D.
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2025, 31 (02) : 308 - 315
  • [23] Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma
    Hirakawa, Akihiro
    Nishikawa, Tadaaki
    Yonemori, Kan
    Shibata, Taro
    Nakamura, Kenichi
    Ando, Masashi
    Ueda, Takafumi
    Ozaki, Toshifumi
    Tamura, Kenji
    Kawai, Akira
    Fujiwara, Yasuhiro
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (03) : 334 - 338
  • [24] Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma
    Akihiro Hirakawa
    Tadaaki Nishikawa
    Kan Yonemori
    Taro Shibata
    Kenichi Nakamura
    Masashi Ando
    Takafumi Ueda
    Toshifumi Ozaki
    Kenji Tamura
    Akira Kawai
    Yasuhiro Fujiwara
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 334 - 338
  • [25] A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers
    Chae, Young Kwang
    Othus, Megan
    Patel, Sandip Pravin
    Edwards, Robert P.
    Scalici, Jennifer Michelle
    Chung, Liam Il-Young
    McLeod, Christine
    Chen, Helen X.
    Sharon, Elad
    Streicher, Howard
    Ryan, Christopher W.
    Blanke, Charles David
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Integrated analysis of two phase 2 trials of nivolumab in metastatic rare solid cancer with dMMR or pMMR (MASTER KEY sub-studies: ROCK and ROLL trial).
    Kanai, Masashi
    Okuma, Hitomi Sumiyoshi
    Tsuchihashi, Kenji
    Machida, Ryunosuke
    Sadachi, Ryo
    Hirakawa, Akihiro
    Kamikura, Masahisa
    Anjo, Kenta
    Sekine, Shigeki
    Okita, Natsuko Tsuda
    Nakamura, Kenichi
    Yonemori, Kan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
123